WASHINGTON - Merck & Co's experimental insomnia drug was safe and effective at the lower of two doses studied, a panel of medical experts said on Wednesday, increasing the chance it will be approved by the U.S. Food and Drug Administration.
BIRMINGHAM, Alabama - U.S. and state health authorities are investigating an unidentified respiratory illness that has killed two of 10 people hospitalized with it in Alabama since last week.
NEW YORK (Reuters Health) - In a new study, people with high blood pressure who could communicate with their pharmacists online had better blood pressure control a year after that service ended.
NEW YORK (Reuters Health) - Daily vitamin C supplements don't lower uric acid as much as drugs used to treat high levels of the acid that's responsible for gout, says a new study from New Zealand.
LOS ANGELES - Los Angeles, which has more storefront medical marijuana shops than any other U.S. city, will close hundreds of the dispensaries and hike taxes on those that will be allowed to remain under a ballot measure approved by a wide margin of voters.
NEW YORK (Reuters Health) - Adults who drink at least one sugar-sweetened drink a day are slightly more likely to develop kidney stones than people who rarely imbibe them, according to a new study.
NEW YORK (Reuters Health) - More than one quarter of people being treated for non-melanoma skin cancer in their doctor's office reported some type of complication after surgery, in a new study.
LONDON - For a pathogen with such a short history, the mysterious new virus killing people in the Middle East and Europe has already had an amazing array of names.
NEW YORK - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipeline of experimental cancer treatments that it aims to deliver at a fraction of the cost spent by larger rivals.
- Montreal, Canada's second-largest city, has asked 1.3 million people to boil their drinking water after a problem at one of the city's water treatment facilities.